[The transcutaneous treatment of superficial thrombophlebitis with the exogenous nitric oxide donor: nitroglycerin].
Nitroglycerin (glyceryl trinitrate) is a substance that is metabolized to nitric oxide in the cell. Its action is not dependent of the endothelium derived nitric oxide, but imitates those of this biological mediator. We thought that nitroglycerin should have the same in vivo actions as the endogenous nitric oxide in vitro has. We report and discuss the first patient with superficial thrombophlebitis successfully treated with transdermal nitroglycerin.
Berrazueta
J R
JR
Servio de Cardiología, Hospital Universitario Marqués de Valdecilla, Santander.
Ochoteco
A
A
Poveda
J J
JJ
Ruiz
B
B
Olalla
J J
JJ
Gutiérrez Escalada
B
B
Salas
E
E
D000208:Acute Disease; D000279:Administration, Cutaneous; D000368:Aged; D001132:Arm / Q000098:blood supply; D006333:Heart Failure / Q000150:complications / Q000628:therapy; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D005996:Nitroglycerin / Q000008:administration & dosage*; D013924:Thrombophlebitis / Q000188:drug therapy* / Q000209:etiology
D005996:Nitroglycerin
Tratamiento transcutáneo de la tromboflebitis superficial con el donador exógeno de óxido nítrico: nitroglicerina.